⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL191201 | 0.80 | — | — | |
| SCHEMBL7735306 | 0.77 | CYP1A2 (0.47) | — | |
| SCHEMBL728483 | 0.72 | — | — | |
| SCHEMBL29649153 | 0.72 | — | — | |
| SCHEMBL467333 | 0.72 | — | — | |
| SCHEMBL23260386 | 0.72 | — | — | |
| SCHEMBL8747477 | 0.72 | CYP2A6 (0.43) | — | |
| SCHEMBL534670 | 0.71 | — | — | |
| SCHEMBL623762 | 0.70 | CYP2A6 (0.41) | — | |
| SCHEMBL12345000 | 0.70 | CYP1A2 (0.72) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080306143-A1 | Cathechins for the Treatment of Fibrillogenesis in Alzheimer's Disease, Parkinson's Disease, Systemic AA Amyloidosis, and Other Amyloid Disorders | PROTAMED, INC. | 2008-12-11 | — | — | US | disclosed |